AI assistant
Sending…
Protara Therapeutics, Inc. — Director's Dealing 2020
Jul 27, 2020
34057_dirs_2020-07-27_e39471e4-29b1-4926-95a4-aba39d3e54aa.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Protara Therapeutics, Inc. (TARA)
CIK: 0001359931
Period of Report: 2020-07-23
Reporting Person: Flannelly Barry P (Director)
More from Protara Therapeutics, Inc.
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Mar 30
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 2
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 27